Cellular Interactions of Cardiac Repair After Myocardial Infarction
Cells · 01.12.2025 · 14 (23) · 1903
DOI: 10.3390/cells14231903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 01.12.2025. Verfasst von Merry L Lindsey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Meharry Medical College, Nashville, TN 37208, USA. Hauptthemen laut MEDLINE: Myocardial Infarction, Cell Communication, Wound Healing, Myocardium. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, Agencia Nacional de Promoción Cientifica y Tecnologica de Argentina, United States Department of Veterans Affairs.
Abstract (Originalsprache)
When blood flow to a part of the myocardial muscle is reduced or blocked, it leads to tissue ischemia in that region. Myocardial infarction (MI) occurs when the ischemic insult is of sufficient duration in time to induce cardiomyocyte death and subsequent activation of the innate immune response. MI initiates a complex cascade of cellular and molecular events within the left ventricle. Inflammatory cells rapidly infiltrate the infarcted area to remove necrotic tissue, setting the stage for reparative wound healing processes. Over the ensuing days, various cell populations—including leukocytes, fibroblasts, and endothelial cells—are attracted to the infarcted site by inflammatory cytokines and chemokines. The activated cells at the site of injury contribute to tissue remodeling and scar formation through the deposition of extracellular matrix components, particularly collagen. While scar formation is essential for structural stabilization of the infarct region to replace the loss of cardiomyocytes, scar tissue also increases myocardial stiffness and impairs cardiac contractile function. This review summarizes our knowledge regarding cellular dynamics, inflammatory signaling, and cardiac remodeling that govern MI healing. We identify the current gaps in the field and provide a foundational resource for those seeking to understand the biological underpinnings of cardiac repair following MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Applied Education, Meharry Medical College, Nashville, TN 37208, USA.
- Research Service, Nashville VA Medical Center, Nashville, TN 37212, USA.
- Department of Integrative Genomics and Epidemiology, Meharry Medical College, Nashville, TN 37208, USA.
- Division of Cardiology, Department of Medicine, School of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
- Research Service, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC 29401, USA.
ORCID-Profile: Merry L Lindsey, Ashton F Oliver, Amadou Gaye, Pius N Nde, Kristine Y DeLeon-Pennell, Germán E González
Förderung
- NIMHD NIH HHS
- Agencia Nacional de Promoción Cientifica y Tecnologica de Argentina
- United States Department of Veterans Affairs
- NIH HHS
- CSRD VA
- American Heart Association
- Chan Zuckerburg Iniative
- Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina
Zitieren
APA
Lindsey, M. L., Oliver, A. F., Gaye, A., Nde, P. N., DeLeon-Pennell, K. Y., & González, G. E. (2025). Cellular Interactions of Cardiac Repair After Myocardial Infarction. Cells, 14(23), 1903. https://doi.org/10.3390/cells14231903
Vancouver
Lindsey ML, Oliver AF, Gaye A, Nde PN, DeLeon-Pennell KY, González GE. Cellular Interactions of Cardiac Repair After Myocardial Infarction. Cells. 2025;14(23):1903. doi:10.3390/cells14231903
BibTeX
@article{Lindsey2025,
author = {Lindsey, Merry L and Oliver, Ashton F and Gaye, Amadou and Nde, Pius N and DeLeon-Pennell, Kristine Y and González, Germán E},
title = {Cellular Interactions of Cardiac Repair After Myocardial Infarction},
journal = {Cells},
year = {2025},
volume = {14},
number = {23},
pages = {1903},
doi = {10.3390/cells14231903}
}
EUVIMED